| Literature DB >> 34066823 |
Simon Jansen1, Ulrich Baulain1, Christin Habig1, Faisal Ramzan2, Jens Schauer1, Armin Otto Schmitt2,3, Armin Manfred Scholz4, Ahmad Reza Sharifi3,5, Annett Weigend1, Steffen Weigend1,3.
Abstract
Skeletal disorders, including fractures and osteoporosis, in laying hens cause major welfare and economic problems. Although genetics have been shown to play a key role in bone integrity, little is yet known about the underlying genetic architecture of the traits. This study aimed to identify genes associated with bone breaking strength and bone mineral density of the tibiotarsus and the humerus in laying hens. Potentially informative single nucleotide polymorphisms (SNP) were identified using Random Forests classification. We then searched for genes known to be related to bone stability in close proximity to the SNPs and identified 16 potential candidates. Some of them had human orthologues. Based on our findings, we can support the assumption that multiple genes determine bone strength, with each of them having a rather small effect, as illustrated by our SNP effect estimates. Furthermore, the enrichment analysis showed that some of these candidates are involved in metabolic pathways critical for bone integrity. In conclusion, the identified candidates represent genes that may play a role in the bone integrity of chickens. Although further studies are needed to determine causality, the genes reported here are promising in terms of alleviating bone disorders in laying hens.Entities:
Keywords: Random Forests; bone breaking strength; bone mineral density; gene set enrichment analysis; osteoporosis; single nucleotide polymorphism; skeletal integrity
Year: 2021 PMID: 34066823 PMCID: PMC8151682 DOI: 10.3390/genes12050702
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Schematic illustration of the study design. The data set included 524 laying hens phenotyped for bone stability traits. The corresponding genotypes included 490,745 SNP markers. Association analysis was performed applying Random Forests (RF) classification. Genes harbouring significant SNPs were extracted and screened for links to bone stability. Gene set analyses were performed considering all genes obtained from the RF classification. Retrospectively, SNP effects were estimated for a subset of candidate genes identified in gene sets obtained from the RF classifier.
General information for 17 loci associated with the bone breaking strengths (BBS) or bone mineral densities (BMD) of the tibiotarsus (Tib) and humerus (Hum) selected for the SNP effects analysis.
| SNP | Trait | Location | GGA 1 | Position 2 | Genotypes | N Individuals | Genotype Frequencies | EA/OA 3 | EA Frequency | Candidate Gene | Reference 4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-75268181 | Tib_BMD | intragenic | 1 | 139,001,157 | CC/CT/TT | 392/96/36 | 0.75/0.18/0.07 | T/C | 0.16 |
| [ |
| AX-76044166 | Tib_BBS | intragenic | 2 | 15,440,861 | AA/AG/GG | 421/63/40 | 0.80/0.12/0.08 | G/A | 0.14 |
| [ |
| AX-80813610 | Tib_BMD | downstream | 2 | 23,056,581 | CC/CG/GG | 339/113/72 | 0.65/0.22/0.13 | G/C | 0.25 |
| [ |
| AX-76099065 | Tib_BMD | intragenic | 2 | 46,101,680 | GG/GA/AA | 392/77/55 | 0.75/0.15/0.10 | A/G | 0.18 |
| [ |
| AX-76601713 | Tib_BBS | intragenic | 3 | 10,617,925 | AA/AG/GG | 265/102/157 | 0.51/0.19/0.30 | G/A | 0.40 |
| [ |
| AX-77276717 | Tib_BBS | intragenic | 3 | 19,498,104 | GG/GA/AA | 322/145/57 | 0.61/0.28/0.11 | A/G | 0.25 |
| [ |
| AX-76491534 | Tib_BBS | intragenic | 3 | 49,027,160 | AA/AG/GG | 432/62/30 | 0.82/0.12/0.06 | G/A | 0.12 |
| [ |
| AX-76772658 | Tib_BBS/Hum_BBS | intragenic | 5 | 11,438,677 | TT/TC/CC | 219/199/109 | 0.41/0.38/0.21 | C/T | 0.40 |
| [ |
| AX-77113061 | Tib_BMD | upstream | 8 | 5,889,886 | GG/AG/AA | 202/156/166 | 0.38/0.30/0.32 | A/G | 0.47 |
| [ |
| AX-77091655 | Hum_BBS/Hum_BMD | upstream | 8 | 24,931,025 | CC/CA/AA | 286/139/99 | 0.54/0.27/0.19 | A/C | 0.32 |
| [ |
| AX-75597497 | Hum_BBS | downstream | 10 | 19,108,829 | AA/AG/GG | 376/124/24 | 0.72/0.24/0.04 | G/A | 0.16 |
| [ |
| AX-75677174 | Tib_BMD | intragenic | 11 | 10,044,055 | CC/CT/TT | 377/107/40 | 0.72/020/0.08 | T/C | 0.18 |
| [ |
| AX-75711229 | Tib_BBS | intragenic | 12 | 3,804,145 | GG/AG/AA | 459/58/7 | 0.88/0.11/0.01 | A/G | 0.07 |
| [ |
| AX-75913642 | Tib_BBS | upstream | 18 | 8,793,585 | GG/AG/AA | 451/61/12 | 0.86/0.12/0.02 | A/G | 0.08 |
| [ |
| AX-76351785 | Hum_BBS | intragenic | 27 | 3,497,444 | CC/CT/TT | 316/138/70 | 0.61/0.26/0.13 | T/C | 0.26 |
| [ |
| AX-76351898 | Hum_BMD | downstream | 27 | 3,518,924 | GG/GA/AA | 483/31/10 | 0.92/0.06/0.02 | A/G | 0.05 |
| [ |
| AX-76351899 | Hum_BMD | downstream | 27 | 3,519,091 | TT/TC/CC | 483/31/10 | 0.92/0.06/0.02 | C/T | 0.05 |
| [ |
1 GGA, Gallus gallus chromosome; 2 Physical position (bp) according to the GRCg6a (galGal6) genome assembly; 3 EA, effect allele (minor allele); OA, other allele (major allele); 4 References from the literature suggesting an association of the gene with bone stability traits.
Figure 2Venn diagram showing the overlap of genes for the bone breaking strengths (BBS) and bone mineral densities (BMD) of the tibiotarsus and humerus.
SNP effects analysis—Part 1: Analysis of variance table and allele substitution effect obtained from the single marker regression model.
| SNP | Trait 1 | Candidate Gene | Generation | Layer Line | SNP Genotype | Allele Substitution Effect 2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F-Statistics | F-Statistics | F-Statistics | Beta (SE 3) | Standardised Beta 4 (SE) | ||||||||
| AX-76044166 | Tib_BBS |
| 80.92 | <0.0001 | 46.34 | <0.0001 | 4.05 | 0.0448 | 8.22 (4.09) | 0.10 (0.05) | 2.01 | 0.0448 |
| AX-76601713 | Tib_BBS |
| 86.02 | <0.0001 | 106.86 | <0.0001 | 13.33 | 0.0003 | −10.19 (2.79) | −0.18 (0.05) | −3.65 | 0.0003 |
| AX-77276717 | Tib_BBS |
| 81.07 | <0.0001 | 102.16 | <0.0001 | 3.32 | 0.0696 | 4.67 (2.57) | 0.06 (0.04) | 1.82 | 0.0696 |
| AX-76491534 | Tib_BBS |
| 91.49 | <0.0001 | 84.86 | <0.0001 | 12.58 | 0.0004 | −15.63 (4.41) | −0.17 (0.05) | −3.55 | 0.0004 |
| AX-76772658 | Tib_BBS |
| 81.50 | <0.0001 | 117.84 | <0.0001 | 10.71 | 0.0012 | 7.63 (2.33) | 0.12 (0.04) | 3.27 | 0.0012 |
| AX-75711229 | Tib_BBS |
| 79.24 | <0.0001 | 84.23 | <0.0001 | 2.08 | 0.1503 | 6.66 (4.62) | 0.05 (0.04) | 1.44 | 0.1503 |
| AX-75913642 | Tib_BBS |
| 83.08 | <0.0001 | 111.94 | <0.0001 | 9.67 | 0.0019 | −12.87 (4.14) | −0.11 (0.04) | −3.11 | 0.0019 |
| AX-76772658 | Hum_BBS |
| 36.26 | <0.0001 | 52.59 | <0.0001 | 5.67 | 0.0177 | −5.32 (2.23) | −0.10 (0.04) | −2.38 | 0.0177 |
| AX-77091655 | Hum_BBS |
| 39.91 | <0.0001 | 41.64 | <0.0001 | 8.35 | 0.0041 | 6.69 (2.31) | 0.13 (0.04) | 2.89 | 0.0041 |
| AX-75597497 | Hum_BBS |
| 36.38 | <0.0001 | 53.40 | <0.0001 | 4.62 | 0.0321 | −7.13 (3.32) | −0.10 (0.05) | −2.15 | 0.0321 |
| AX-76351785 | Hum_BBS |
| 37.27 | <0.0001 | 67.22 | <0.0001 | 21.57 | <0.0001 | 11.51 (2.48) | 0.21 (0.04) | 4.64 | <0.0001 |
| AX-75268181 | Tib_BMD |
| 4.30 | 0.0401 | 106.46 | <0.0001 | 13.53 | 0.0003 | −0.015 (0.004) | −0.15 (0.05) | −3.67 | 0.0003 |
| AX-80813610 | Tib_BMD |
| 4.24 | 0.0415 | 56.10 | <0.0001 | 4.86 | 0.0298 | 0.008 (0.004) | 0.10 (0.05) | 2.21 | 0.028 |
| AX-76099065 | Tib_BMD |
| 4.31 | 0.0400 | 65.23 | <0.0001 | 8.55 | 0.0036 | −0.016 (0.006) | −0.18 (0.06) | −2.92 | 0.0036 |
| AX-77113061 | Tib_BMD |
| 4.45 | 0.0369 | 99.26 | <0.0001 | 5.27 | 0.0221 | 0.008 (0.003) | 0.11 (0.05) | 2.30 | 0.0221 |
| AX-75677174 | Tib_BMD |
| 4.27 | 0.0406 | 61.13 | <0.0001 | 10.84 | 0.0011 | 0.013 (0.004) | 0.13(0.04) | 3.29 | 0.0011 |
| AX-77091655 | Hum_BMD |
| 20.70 | <0.0001 | 51.56 | <0.0001 | 11.53 | 0.0008 | 0.007 (0.002) | 0.14 (0.04) | 3.39 | 0.0008 |
| AX-76351898 | Hum_BMD |
| 19.82 | <0.0001 | 77.58 | <0.0001 | 13.81 | 0.0002 | 0.016 (0.004) | 0.15 (0.04) | 3.72 | 0.0002 |
| AX-76351899 | Hum_BMD |
| 19.82 | <0.0001 | 77.58 | <0.0001 | 13.81 | 0.0002 | 0.016 (0.004) | 0.15 (0.04) | 3.72 | 0.0002 |
1 BBS, bone breaking strength; BMD, bone mineral density; Tib, tibiotarsus; Hum, humerus; 2 Allele substitution effect per copy of the effect allele (minor allele); 3 SE, standard error; 4 Standardised regression coefficients expressed in SD unit.
SNP effects analysis—Part 2: Genotypic values (least squares means) and additive and dominance effects obtained from the dominant-recessive model.
| SNP | Trait 1 | Candidate Gene | Genotypic Values | Homozygous Additive Allele Effect 5 | Dominance Effect 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AA 2,3 (SE 4) | AB 2,3 (SE) | BB 2,3 (SE) | Estimate (SE) | Estimate (SE) | |||||||
| AX-76044166 | Tib_BBS |
| 155.33 (2.26) ab | 145.80 (5.85) b | 172.76 (7.25) a | −8.71 (4.05) | −2.15 | 0.0320 | −18.20 (5.45) | −3.35 | 0.0009 |
| AX-76601713 | Tib_BBS |
| 162.77 (3.08) a | 156.79 (3.81) a | 143.10 (3.79) b | 9.83 (2.82) | 3.49 | 0.0005 | 3.86 (4.03) | 0.96 | 0.3392 |
| AX-77276717 | Tib_BBS |
| 153.42 (2.25) a | 157.05 (3.06) a | 163.72 (5.10) a | −5.15 (2.83) | −1.82 | 0.0694 | −1.52 (3.73) | −0.41 | 0.6843 |
| AX-76491534 | Tib_BBS |
| 159.13 (2.19) a | 144.04 (6.28) ab | 127.83 (8.09) b | 15.70 (4.42) | 3.54 | 0.0004 | 0.56 (5.88) | 0.096 | 0.9239 |
| AX-76772658 | Tib_BBS |
| 149.06 (2.65) b | 158.53 (2.58) a | 163.29 (3.90) a | −7.11 (2.43) | −2.93 | 0.0035 | 2.36 (3.13) | 0.75 | 0.4520 |
| AX-75711229 | Tib_BBS |
| 155.14 (1.94) b | 154.78 (5.29) b | 188.53 (13.11) a | −16.70 (6.62) | −2.52 | 0.0120 | −17.10 (8.02) | −2.13 | 0.0340 |
| AX-75913642 | Tib_BBS |
| 157.50 (1.93) a | 148.13 (4.83) ab | 124.13 (10.37) b | 16.70 (5.31) | 3.14 | 0.0018 | 7.40 (6.44) | 1.15 | 0.2506 |
| AX-76772658 | Hum_BBS |
| 127.04 (2.51) a | 116.24 (2.46) b | 119.38 (3.71) ab | 3.83 (2.31) | 1.66 | 0.0984 | −6.96 (3.02) | −2.31 | 0.0215 |
| AX-77091655 | Hum_BBS |
| 118.01 (2.31) b | 120.73 (3.04) b | 132.21 (3.73) a | −7.10 (2.31) | −3.07 | 0.0023 | −4.38 (3.44) | −1.27 | 0.2043 |
| AX-75597497 | Hum_BBS |
| 122.16 (2.08) a | 123.48 (3.64) a | 98.16 (6.97) b | 12.0 (3.71) | 3.23 | 0.0013 | 13.30 (4.61) | 2.88 | 0.0040 |
| AX-76351785 | Hum_BBS |
| 115.73 (2.19) c | 124.86 (3.05) b | 139.61 (4.34) a | −11.90 (2.54) | −4.70 | <0.0001 | −2.81 (3.49) | −0.80 | 0.4215 |
| AX-75268181 | Tib_BMD |
| 0.263 (0.003) a | 0.253 (0.005) a | 0.228 (0.008) b | 0.017 (0.004) | 3.92 | 0.0001 | 0.008 (0.006) | 1.35 | 0.1768 |
| AX-80813610 | Tib_BMD |
| 0.256 (0.003) a | 0.258 (0.005) a | 0.273 (0.006) a | −0.009 (0.004) | −2.24 | 0.0257 | −0.007 (0.005) | −1.27 | 0.2051 |
| AX-76099065 | Tib_BMD |
| 0.261 (0.003) ab | 0.265 (0.008) a | 0.235 (0.009) b | 0.013 (0.006) | 2.32 | 0.0206 | 0.018 (0.006) | 2.71 | 0.0071 |
| AX-77113061 | Tib_BMD |
| 0.246 (0.005) a | 0.267 (0.004) a | 0.266 (0.004) a | −0.01 (0.004) | −2.82 | 0.0050 | 0.011 (0.004) | 2.51 | 0.0125 |
| AX-75677174 | Tib_BMD |
| 0.254 (0.003) b | 0.269 (0.005) a | 0.278 (0.007) a | −0.012 (0.004) | −3.05 | 0.0024 | 0.004 (0.005) | 0.56 | 0.5739 |
| AX-77091655 | Hum_BMD |
| 0.164 (0.002) b | 0.167 (0.003) b | 0.178 (0.003) a | −0.007 (0.002) | −3.53 | 0.0005 | −0.004 (0.003) | −1.25 | 0.2117 |
| AX-76351898 | Hum_BMD |
| 0.166 (0.002) b | 0.176 (0.006) b | 0.206 (0.010) a | −0.02 (0.005) | −3.84 | 0.0001 | −0.009 (0.007) | −1.29 | 0.1991 |
| AX-76351899 | Hum_BMD |
| 0.166 (0.002) b | 0.176 (0.006) b | 0.206 (0.010) a | −0.02 (0.005) | −3.84 | 0.0001 | −0.009 (0.007) | −1.29 | 0.1991 |
1 BBS, bone breaking strength; BMD, bone mineral density; Tib, tibiotarsus; Hum, humerus; 2 AA or BB represents the homozygote of the other allele or effect allele, respectively. AB denotes the heterozygote (see Table 1 for the actual genotypes); 3 Means with different letters within a column differ significantly at p < 0.05; 4 SE, standard error; 5 Effect of the other allele (major allele).
Figure 3Significantly enriched Gene Ontology terms of the category biological processes (GO:BP; top 15 with the highest -log10 p-values) and KEGG pathways for the bone breaking strength (A) and bone mineral density (B) of the tibiotarsus. The dot size represents the absolute number of genes enriched in the term. The proportion of enriched genes in all queried genes is represented on the x-axis. The colour represents the −log10 transformed adjusted p-values.
Figure 4Significantly enriched Gene Ontology terms of the category biological processes (GO:BP; top 15 with the highest -log10 p-values) and KEGG pathways for the bone breaking strength (A) and bone mineral density (B) of the humerus. The dot size represents the absolute number of genes enriched in the term. The proportion of enriched genes in all queried genes is represented on the x-axis. The colour represents the −log10 transformed adjusted p-values.